d.tumorscreen: Comparing Universal Lynch Syndrome Tumor-Screening Programs

Description Usage Format Contributors Author(s) Source


This dataset is from Cragun et al. (2014), who analyze the association between different universal tumor screening procedures and certain levels of patient follow-through with germ-line testing for Lynch Syndrome after a screen-positive result using csQCA.




This data frame contains 15 rows (cases) and the following 8 columns (factors):

[ , 1] HPF endogenous factor: high patient follow-through ("1" yes, "0" no)
[ , 2] LPF endogenous factor: low patient follow-through ("1" yes, "0" no)
[ , 3] CA exogenous factor: challenges to adoption at least as high as facilitators ("1" yes, "0" no)
[ , 4] AR exogenous factor: automatic reflex test of screen-positive tumors ("1" yes, "0" no)
[ , 5] RR exogenous factor: genetic counselor receives positive screen results ("1" yes, "0" no)
[ , 6] DR exogenous factor: genetic counselor discloses screening result to patient ("1" yes, "0" no)
[ , 7] DC exogenous factor: difficulty in contacting patients ("1" yes, "0" no)
[ , 8] PR exogenous factor: need for physician referral is a barrier ("1" yes, "0" no)


Thiem, Alrik: collection, documentation


Alrik Thiem (Personal Website; ResearchGate Website)


Cragun, Deborah, Rita D. DeBate, Susan T. Vadaparampil, Julie Baldwin, Heather Hampel, and Tuya Pal. 2014. “Comparing Universal Lynch Syndrome Tumor-Screening Programs to Evaluate Associations between Implementation Strategies and Patient Follow-Through.” Genetics in Medicine 16 (10):773-82. DOI: 10.1038/gim.2014.31.

QCApro documentation built on May 1, 2019, 10:09 p.m.

Related to d.tumorscreen in QCApro...